Seattle scientists help unveil ‘landmark’ findings on human brain

A global team of researchers, including scientists from the Allen Institute in Seattle, has published the most detailed cellular atlas of the basal ganglia to date. This landmark study identifies a new brain cell type linked to schizophrenia and bipolar disorder, potentially paving the way for more targeted medical treatments.
Why it matters
Mapping the brain's 'Grand Central' region provides a foundation for understanding and treating complex neurological and psychiatric conditions.
Touching your nose. Climbing stairs. Developing tremors. Processing rewards.
These actions, and more, are largely controlled by one particular part of the human brain, a golf ball-sized network of cells and nerves responsible for voluntary movement, decision-making and forming habits.
The basal ganglia is also tied to some widespread and confounding illnesses — and new research, aided by scientists in Seattle, is expected to propel discovery, and eventually, treatment.
This group of cells sits near the middle of the brain, wedged under the neocortex and above the brainstem. Experts call it one of the brain’s most important regions, largely because it’s known as the “Grand Central of brain diseases,” says Seattle neuroscientist Ed Lein.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in